Literature DB >> 17085555

Complete and SOS-mediated response of Staphylococcus aureus to the antibiotic ciprofloxacin.

Ryan T Cirz1, Marcus B Jones, Neill A Gingles, Timothy D Minogue, Behnam Jarrahi, Scott N Peterson, Floyd E Romesberg.   

Abstract

Staphylococcus aureus infections can be difficult to treat due to both multidrug resistance and the organism's remarkable ability to persist in the host. Persistence and the evolution of resistance may be related to several complex regulatory networks, such as the SOS response, which modifies transcription in response to environmental stress. To understand how S. aureus persists during antibiotic therapy and eventually emerges resistant, we characterized its global transcriptional response to ciprofloxacin. We found that ciprofloxacin induces prophage mobilization as well as significant alterations in metabolism, most notably the up-regulation of the tricarboxylic acid cycle. In addition, we found that ciprofloxacin induces the SOS response, which we show, by comparison of a wild-type strain and a non-SOS-inducible lexA mutant strain, includes the derepression of 16 genes. While the SOS response of S. aureus is much more limited than those of Escherichia coli and Bacillus subtilis, it is similar to that of Pseudomonas aeruginosa and includes RecA, LexA, several hypothetical proteins, and a likely error-prone Y family polymerase whose homologs in other bacteria are required for induced mutation. We also examined induced mutation and found that either the inability to derepress the SOS response or the lack of the LexA-regulated polymerase renders S. aureus unable to evolve antibiotic resistance in vitro in response to UV damage. The data suggest that up-regulation of the tricarboxylic acid cycle and induced mutation facilitate S. aureus persistence and evolution of resistance during antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17085555      PMCID: PMC1797410          DOI: 10.1128/JB.01464-06

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  44 in total

1.  A sliding-clamp toolbelt binds high- and low-fidelity DNA polymerases simultaneously.

Authors:  Chiara Indiani; Peter McInerney; Roxana Georgescu; Myron F Goodman; Mike O'Donnell
Journal:  Mol Cell       Date:  2005-09-16       Impact factor: 17.970

2.  Cleavage of LexA repressor.

Authors:  J W Little; B Kim; K L Roland; M H Smith; L L Lin; S N Slilaty
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

3.  Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase.

Authors:  J D McKinney; K Höner zu Bentrup; E J Muñoz-Elías; A Miczak; B Chen; W T Chan; D Swenson; J C Sacchettini; W R Jacobs; D G Russell
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

4.  Comparative gene expression profiles following UV exposure in wild-type and SOS-deficient Escherichia coli.

Authors:  J Courcelle; A Khodursky; B Peter; P O Brown; P C Hanawalt
Journal:  Genetics       Date:  2001-05       Impact factor: 4.562

5.  Contribution of the mismatch DNA repair system to the generation of stationary-phase-induced mutants of Bacillus subtilis.

Authors:  Mario Pedraza-Reyes; Ronald E Yasbin
Journal:  J Bacteriol       Date:  2004-10       Impact factor: 3.490

6.  Distinctive genetic features exhibited by the Y-family DNA polymerases in Bacillus subtilis.

Authors:  Stéphane Duigou; S Dusko Ehrlich; Philippe Noirot; Marie-Françoise Noirot-Gros
Journal:  Mol Microbiol       Date:  2004-10       Impact factor: 3.501

7.  Binding of the Bacillus subtilis LexA protein to the SOS operator.

Authors:  Eli S Groban; Martha B Johnson; Poopak Banky; Peta-Gaye G Burnett; Georgina L Calderon; Erica C Dwyer; Shakierah N Fuller; Biniam Gebre; Leah M King; Ila N Sheren; Lindi D Von Mutius; Thomas M O'Gara; Charles M Lovett
Journal:  Nucleic Acids Res       Date:  2005-11-03       Impact factor: 16.971

8.  Inhibition of mutation and combating the evolution of antibiotic resistance.

Authors:  Ryan T Cirz; Jodie K Chin; David R Andes; Valérie de Crécy-Lagard; William A Craig; Floyd E Romesberg
Journal:  PLoS Biol       Date:  2005-05-10       Impact factor: 8.029

9.  An SOS-regulated operon involved in damage-inducible mutagenesis in Caulobacter crescentus.

Authors:  Rodrigo S Galhardo; Raquel P Rocha; Marilis V Marques; Carlos F M Menck
Journal:  Nucleic Acids Res       Date:  2005-05-10       Impact factor: 16.971

10.  Physiological characterization of Pseudomonas aeruginosa during exotoxin A synthesis: glutamate, iron limitation, and aconitase activity.

Authors:  G Somerville; C A Mikoryak; L Reitzer
Journal:  J Bacteriol       Date:  1999-02       Impact factor: 3.476

View more
  104 in total

Review 1.  Essential biological processes of an emerging pathogen: DNA replication, transcription, and cell division in Acinetobacter spp.

Authors:  Andrew Robinson; Anthony J Brzoska; Kylie M Turner; Ryan Withers; Elizabeth J Harry; Peter J Lewis; Nicholas E Dixon
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

Review 2.  SOS response and its regulation on the fluoroquinolone resistance.

Authors:  Ting-Ting Qin; Hai-Quan Kang; Ping Ma; Peng-Peng Li; Lin-Yan Huang; Bing Gu
Journal:  Ann Transl Med       Date:  2015-12

3.  Antibiotics Stimulate Formation of Vesicles in Staphylococcus aureus in both Phage-Dependent and -Independent Fashions and via Different Routes.

Authors:  Federica Andreoni; Masanori Toyofuku; Annelies S Zinkernagel; Leo Eberl; Carmen Menzi; Ratchara Kalawong; Srikanth Mairpady Shambat; Patrice François
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

Review 4.  DNA damage responses in prokaryotes: regulating gene expression, modulating growth patterns, and manipulating replication forks.

Authors:  Kenneth N Kreuzer
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-11-01       Impact factor: 10.005

5.  ω-Hydroxyemodin limits staphylococcus aureus quorum sensing-mediated pathogenesis and inflammation.

Authors:  Seth M Daly; Bradley O Elmore; Jeffrey S Kavanaugh; Kathleen D Triplett; Mario Figueroa; Huzefa A Raja; Tamam El-Elimat; Heidi A Crosby; Jon K Femling; Nadja B Cech; Alexander R Horswill; Nicholas H Oberlies; Pamela R Hall
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

6.  Effects of subinhibitory concentrations of antibiotics on SOS and DNA repair gene expression in Staphylococcus aureus.

Authors:  Lili Rosana Mesak; Vivian Miao; Julian Davies
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

7.  Fate of mutation rate depends on agr locus expression during oxacillin-mediated heterogeneous-homogeneous selection in methicillin-resistant Staphylococcus aureus clinical strains.

Authors:  Konrad B Plata; Roberto R Rosato; Adriana E Rosato
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

8.  Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections.

Authors:  Jill M Butterfield; Brian T Tsuji; Jack Brown; Elizabeth Dodds Ashley; Dwight Hardy; Kristen Brown; Alan Forrest; Thomas P Lodise
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

9.  DNA Targeting as a Likely Mechanism Underlying the Antibacterial Activity of Synthetic Bis-Indole Antibiotics.

Authors:  Timothy J Opperman; Steven M Kwasny; Jessica Bo Li; Mark A Lewis; Daniel Aiello; John D Williams; Norton P Peet; Donald T Moir; Terry L Bowlin; Eric C Long
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

10.  Revealing fosfomycin primary effect on Staphylococcus aureus transcriptome: modulation of cell envelope biosynthesis and phosphoenolpyruvate induced starvation.

Authors:  Marko Petek; Spela Baebler; Drago Kuzman; Ana Rotter; Zdravko Podlesek; Kristina Gruden; Maja Ravnikar; Uros Urleb
Journal:  BMC Microbiol       Date:  2010-06-01       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.